Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01712022 · ClinicalTrials.gov registry record
Evaluation of Corneal Epithelial Thickness Mapping
A clinical trial, sponsored by Optovue.
- Completed
- Registry status
- 88
- Enrollment target
NCT01712022 is a clinical trial that has completed, run by Optovue. The registered enrollment target is 88 participants.
The verdict
NCT01712022 has completed, sponsored by Optovue.
- COMPLETED
- Registry status
- 88 participants
- Enrollment target
Study Summary
Optovue has developed a new feature for mapping corneal epithelial thickness. The purpose of the study is to evaluate the accuracy and repeatability of the epithelial thickness measurement. Consented subjects will undergo a series of cornea measurements using optical coherence tomography (OCT) that will be used for analysis.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2012-10 |
| Est. Completion | 2013-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01712022
The ClinicalTrials.gov registry entry for NCT01712022 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 88 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Optovue, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01712022 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01712022 about?
NCT01712022 is a clinical study titled "Evaluation of Corneal Epithelial Thickness Mapping". Optovue has developed a new feature for mapping corneal epithelial thickness. The purpose of the study is to evaluate the accuracy and repeatability of the epithelial thickness measurement. Consented subjects will undergo a series of cornea measurements using optical coherence tomography (OCT) that ...
What is the current status of trial NCT01712022?
This trial is currently completed. The enrollment target is 88 participants. The study started on 2012-10. Estimated completion is 2013-11.
Who is sponsoring clinical trial NCT01712022?
This trial is sponsored by Optovue, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.